CA2441886C - Method and apparatus for reducing mitral regurgitation - Google Patents
Method and apparatus for reducing mitral regurgitation Download PDFInfo
- Publication number
- CA2441886C CA2441886C CA002441886A CA2441886A CA2441886C CA 2441886 C CA2441886 C CA 2441886C CA 002441886 A CA002441886 A CA 002441886A CA 2441886 A CA2441886 A CA 2441886A CA 2441886 C CA2441886 C CA 2441886C
- Authority
- CA
- Canada
- Prior art keywords
- anchor
- distal
- flexible body
- coronary sinus
- proximal anchor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2451—Inserts in the coronary sinus for correcting the valve shape
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
- Y10S623/902—Method of implanting
- Y10S623/903—Blood vessel
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Abstract
Apparatus (100) for reducing mitral regurgitation, by applying a force to the wall of the coronary sinus (30) so as to force the posterior leaflet (39) anteriorly and thereby reduce mitral regurgitation.
Description
'SqO 02/076284 IPCT/U502/08605 METHOD AND APPARATUS FOR REDUCING MITRAL REGURGITATION
Reference To Pending Prior Patent Applications This patent application:
(1) claims the benefit of U.S. Patent Application Serial No. 10/068,264, filed 02/05/02 by Daniel C:
Taylor et al. for METHOD AND APPARATUS FOR IMPROVING
MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-29), which issued as U.S. Patent No. 6,656,221;
Reference To Pending Prior Patent Applications This patent application:
(1) claims the benefit of U.S. Patent Application Serial No. 10/068,264, filed 02/05/02 by Daniel C:
Taylor et al. for METHOD AND APPARATUS FOR IMPROVING
MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-29), which issued as U.S. Patent No. 6,656,221;
(2) claims the benefit of U.S. Patent Application Serial No. 10/068,700, filed 02/05/02 by William E. Cohn et al. for APPARATUS AND METHOD FOR REDUCING MITRAL
REGURGTTATIaN (Attorney's Docket No. VIA-16), which issued as U.S. Patent No. 6,790,231;
REGURGTTATIaN (Attorney's Docket No. VIA-16), which issued as U.S. Patent No. 6,790,231;
(3) claims the benefit of U.S. Patent Application Serial No. 10/090,968, filed 03/05/02 by William E. Cohn et al. for APPARATUS AND METHOD FOR REDUCING MITRAL
REGURGITATION (Attorney's Docket No. VIA-17), which published as US 2002/0183837;
REGURGITATION (Attorney's Docket No. VIA-17), which published as US 2002/0183837;
(4) claims the benefit of U.S_ Provisional Patent Application Serial No. 60/27B,153, filed 03/23/01 by William E. Cohn et al. for METHOD AND
APPPARATUS TO IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-18 PROV);
APPPARATUS TO IMPROVE MITRAL VALVE FUNCTION (Attorney's Docket No. VIA-18 PROV);
(5) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/279,974, filed 03/29/01 by Daniel C. Taylor et al. for METHOD
AND APPARATUS TO IMPROVE MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-19 PROV);
Provisional Patent Application Serial No. 60/279,974, filed 03/29/01 by Daniel C. Taylor et al. for METHOD
AND APPARATUS TO IMPROVE MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-19 PROV);
(6) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/280,038, filed 03/30/01 by William E. Cohn et al. for METHODS
AND APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE
FUNCTION (Attorney's Docket No. VIA-20 PROV);
Provisional Patent Application Serial No. 60/280,038, filed 03/30/01 by William E. Cohn et al. for METHODS
AND APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE
FUNCTION (Attorney's Docket No. VIA-20 PROV);
(7) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/279,973, filed 03/29/01 by Daniel C. Taylor et al. for METHODS
AND DEVICES TO IMPROVE MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-21 PROV);
Provisional Patent Application Serial No. 60/279,973, filed 03/29/01 by Daniel C. Taylor et al. for METHODS
AND DEVICES TO IMPROVE MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-21 PROV);
(8) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/283,820, filed 04/13/01 by William E. Cohn et al. for METHOD AND
APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE
FUNCTION (Attorney's Docket No. VIA-22 PROV);
Provisional Patent Application Serial No. 60/283,820, filed 04/13/01 by William E. Cohn et al. for METHOD AND
APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE
FUNCTION (Attorney's Docket No. VIA-22 PROV);
(9) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/312,217, filed 08/14/01 by Daniel C. Taylor et al. for METHOD
AND APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE
FUNCTION (Attorney's Docket No. VIA-23 PROV);
Provisional Patent Application Serial No. 60/312,217, filed 08/14/01 by Daniel C. Taylor et al. for METHOD
AND APPARATUS FOR TEMPORARY IMPROVEMENT IN MITRAL VALVE
FUNCTION (Attorney's Docket No. VIA-23 PROV);
(10) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/339,481, filed 10/26/01 by William E. Cohn et al. for TRANSVASCULAR APPROACH TO MITRAL VALVE PROCEDURES
(Attorney's Docket No. VIA-30 PROV); and (11) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/348,424, filed 01/14/02 by Daniel C. Taylor et al. for METHOD
AND APPARATUS TO IMPROVE MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-31 PROV).
The aforementioned eleven (11) patent applications are hereby incorporated herein by reference.
Field Of The Invention This invention relates to surgical methods and apparatus in general, and more particularly to surgical methods and apparatus for improving mitral valve function.
Background Of The Invention Mitral valve repair is the procedure of choice to correct mitral regurgitation of all etiologies. With the use of current surgical techniques, between 70% and 95% of regurgitant mitral valves can be repaired. The advantages of mitral valve repair over mitral valve replacement are well documented. These include better preservation of cardiac function and reduced risk of anticoagulant-related hemorrhage, thromboembolism and endocarditis.
In current practice, mitral valve surgery requires an extremely invasive approach that includes a chest wall incision, cardiopulmonary bypass, cardiac and pulmonary arrest, and an incision on the heart itself to gain access to the mitral valve. Such a procedure is associated with high morbidity and mortality. Due to the risks associated with this procedure, many of the sickest patients are denied the potential benefits of surgical correction of mitral regurgitation. In addition, patients with moderate, symptomatic mitral regurgitation are denied early intervention and undergo surgical correction only after the development of cardiac dysfunction.
Mitral regurgitation is a common occurrence in patients with heart failure and a source of important morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometric configurations of the left ventricle, papillary muscles and mitral annulus. These geometric alterations result in mitral leaflet tethering and incomplete coaptation at systole. In this situation, mitral regurgitation is corrected by plicating the mitral valve annulus, either by (i) sutures alone or by (ii) sutures in combination with a support ring, so as to reduce the circumference of the distended annulus and restore the original geometry of the mitral valve annulus.
More particularly, current surgical practice for mitral valve repair generally requires that the posterior mitral valve annulus be reduced in radius by surgically opening the left atrium and then fixing sutures, or sutures in combination with a support ring, to the internal surface of the annulus; this structure is used to pull the annulus back into a smaller radius, thereby reducing mitral regurgitation by improving leaflet coaptation.
This method of mitral valve repair, generally termed "annuloplasty", effectively reduces mitral regurgitation in heart failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longetivity.
Unfortunately, however, the invasive nature of mitral valve surgery and the attendant risks render most heart failure patients poor surgical candidates. Thus, a less invasive means to increase leaflet coaptation and thereby reduce mitral regurgitation in heart failure patients would make this therapy available to a much greater percentage of patients.
Mitral regurgitation also occurs in approximately 20% of patients suffering acute myocardial infarction.
In addition, mitral regurgitation is the primary cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability in the setting of acute myocardial infarction. Patients with mitral regurgitation and cardiogenic shock have about a 50% hospital mortality. Elimination of mitral regurgitation in these patients would be of significant benefit. Unfortunately, however, patients with acute mitral regurgitation complicating acute myocardial infarction are particularly high-risk surgical candidates, and are therefore not good candidates for a traditional annuloplasty procedure. Thus, a minimally invasive means to effect a temporary reduction or elimination of mitral regurgitation in these critically ill patients would afford them the time to recover from the myocardial infarction or other acute life-threatening events and make them better candidates for medical, interventional or surgical therapy.
A less invasive means to reduce mitral regurgitation would also be an attractive alternative for patients needing to undergo any of the following procedures: (a) isolated mitral valve repair, (b) multiple valve procedures, (c) mitral repair and coronary artery bypass, (d) mitral valve repair and other surgical procedure, or (e) mitral valve repair and an interventional cardiac procedure.
Summary Of The Invention As a result, one object of the present invention is to provide a method and apparatus for treating - $ -mitral regurgitation which does not suffer from the disadvantages associated with conventional annuloplasty.
Another object of the present invention is to provide a method and apparatus for treating mitral regurgitation which can be deployed either permanently (e.g., for patients suffering from heart failure) or temporarily (e.g., for patients suffering from mitral regurgitation with acute myocardial infarction).
Another object of the present invention is to provide a minimally invasive method and apparatus for the repair of heart valves to improve their function.
Another object of the present invention is to provide a method and apparatus for the repair of the mitral valve that eliminates the need for cardiopulmonary bypass and/or cardiac arrest and/or general anesthesia.
Another object of the present invention is to provide a method and apparatus for the repair of the mitral valve that facilitates the use of smaller incisions.
Another object of the present invention is to provide a method and apparatus to effect a change in the geometry of the annulus of the mitral valve that increases mitral leaflet coaptation and reduces mitral valve regurgitation.
Another object of the present invention is to provide a method and apparatus to effect a change in the geometry of the left atrium that increases mitral leaflet coaptation and reduces mitral regurgitation.
Another object of the present invention is to provide an apparatus that is anchored partially or wholly outside the coronary sinus such that tension can be created between the proximal and distal anchored points so as to move these two points closer together and thereby effect a favorable change in the geometry of the mitral valve annulus.
Another object of the present invention is to provide an apparatus that is anchored partially or wholly outside the coronary sinus such that tension can be created between the proximal and distal anchored points so as to move these two points closer together and thereby effect a favorable change in left atrial geometry, with minimal, if any, trauma to the blood vessel.
Another object of the present invention is to provide a method and apparatus to alter the geometry of the mitral valve annulus such that (1) the distance between the anterior and posterior mitral leaflets is shortened; and (2) the coronary sinus assumes a more straight course.
Another object of the present invention is to provide a method and apparatus to alter left atrial geometry such that (1) the distance between the anterior and posterior mitral leaflets is shortened;
and (2) the coronary sinus assumes a more straight course.
Another object of the present invention is to provide a method and apparatus for altering the geometry of the mitral valve annulus in an adjustable and/or reversible fashion such that the effect on mitral valve function can be adjusted so as to achieve the best possible result.
Another object of the present invention is to provide a method and apparatus for altering left atrial geometry in an adjustable and/or reversible fashion such that the effect on mitral valve function can be adjusted so as to achieve the best possible result.
Another object of the present invention is to provide an apparatus that is anchored partially or wholly outside the coronary sinus such that a greater geometric change in the left atrium can be created (that in turn increases mitral leaflet coaptation and reduces mitral regurgitation) when compared to anchoring only within the coronary sinus.
These and other objects are addressed by the present invention, which is made possible by the discovery that the mitral annulus may be remodeled without the plication of conventional, open-surgery annuloplasty.
The present invention comprises a method and apparatus for increasing mitral leaflet coaptation without direct surgical exposure of the mitral valve via the left atrium. More particularly, the present invention comprises a method and apparatus for effecting a geometric, conformational or dimensional alteration in the annulus of the mitral valve by manipulating cardiac structures external to the left atrium and, in so doing, improving mitral valve function.
Provisional Patent Application Serial No. 60/339,481, filed 10/26/01 by William E. Cohn et al. for TRANSVASCULAR APPROACH TO MITRAL VALVE PROCEDURES
(Attorney's Docket No. VIA-30 PROV); and (11) claims benefit of pending prior U.S.
Provisional Patent Application Serial No. 60/348,424, filed 01/14/02 by Daniel C. Taylor et al. for METHOD
AND APPARATUS TO IMPROVE MITRAL VALVE FUNCTION
(Attorney's Docket No. VIA-31 PROV).
The aforementioned eleven (11) patent applications are hereby incorporated herein by reference.
Field Of The Invention This invention relates to surgical methods and apparatus in general, and more particularly to surgical methods and apparatus for improving mitral valve function.
Background Of The Invention Mitral valve repair is the procedure of choice to correct mitral regurgitation of all etiologies. With the use of current surgical techniques, between 70% and 95% of regurgitant mitral valves can be repaired. The advantages of mitral valve repair over mitral valve replacement are well documented. These include better preservation of cardiac function and reduced risk of anticoagulant-related hemorrhage, thromboembolism and endocarditis.
In current practice, mitral valve surgery requires an extremely invasive approach that includes a chest wall incision, cardiopulmonary bypass, cardiac and pulmonary arrest, and an incision on the heart itself to gain access to the mitral valve. Such a procedure is associated with high morbidity and mortality. Due to the risks associated with this procedure, many of the sickest patients are denied the potential benefits of surgical correction of mitral regurgitation. In addition, patients with moderate, symptomatic mitral regurgitation are denied early intervention and undergo surgical correction only after the development of cardiac dysfunction.
Mitral regurgitation is a common occurrence in patients with heart failure and a source of important morbidity and mortality in these patients. Mitral regurgitation in patients with heart failure is caused by changes in the geometric configurations of the left ventricle, papillary muscles and mitral annulus. These geometric alterations result in mitral leaflet tethering and incomplete coaptation at systole. In this situation, mitral regurgitation is corrected by plicating the mitral valve annulus, either by (i) sutures alone or by (ii) sutures in combination with a support ring, so as to reduce the circumference of the distended annulus and restore the original geometry of the mitral valve annulus.
More particularly, current surgical practice for mitral valve repair generally requires that the posterior mitral valve annulus be reduced in radius by surgically opening the left atrium and then fixing sutures, or sutures in combination with a support ring, to the internal surface of the annulus; this structure is used to pull the annulus back into a smaller radius, thereby reducing mitral regurgitation by improving leaflet coaptation.
This method of mitral valve repair, generally termed "annuloplasty", effectively reduces mitral regurgitation in heart failure patients. This, in turn, reduces symptoms of heart failure, improves quality of life and increases longetivity.
Unfortunately, however, the invasive nature of mitral valve surgery and the attendant risks render most heart failure patients poor surgical candidates. Thus, a less invasive means to increase leaflet coaptation and thereby reduce mitral regurgitation in heart failure patients would make this therapy available to a much greater percentage of patients.
Mitral regurgitation also occurs in approximately 20% of patients suffering acute myocardial infarction.
In addition, mitral regurgitation is the primary cause of cardiogenic shock in approximately 10% of patients who develop severe hemodynamic instability in the setting of acute myocardial infarction. Patients with mitral regurgitation and cardiogenic shock have about a 50% hospital mortality. Elimination of mitral regurgitation in these patients would be of significant benefit. Unfortunately, however, patients with acute mitral regurgitation complicating acute myocardial infarction are particularly high-risk surgical candidates, and are therefore not good candidates for a traditional annuloplasty procedure. Thus, a minimally invasive means to effect a temporary reduction or elimination of mitral regurgitation in these critically ill patients would afford them the time to recover from the myocardial infarction or other acute life-threatening events and make them better candidates for medical, interventional or surgical therapy.
A less invasive means to reduce mitral regurgitation would also be an attractive alternative for patients needing to undergo any of the following procedures: (a) isolated mitral valve repair, (b) multiple valve procedures, (c) mitral repair and coronary artery bypass, (d) mitral valve repair and other surgical procedure, or (e) mitral valve repair and an interventional cardiac procedure.
Summary Of The Invention As a result, one object of the present invention is to provide a method and apparatus for treating - $ -mitral regurgitation which does not suffer from the disadvantages associated with conventional annuloplasty.
Another object of the present invention is to provide a method and apparatus for treating mitral regurgitation which can be deployed either permanently (e.g., for patients suffering from heart failure) or temporarily (e.g., for patients suffering from mitral regurgitation with acute myocardial infarction).
Another object of the present invention is to provide a minimally invasive method and apparatus for the repair of heart valves to improve their function.
Another object of the present invention is to provide a method and apparatus for the repair of the mitral valve that eliminates the need for cardiopulmonary bypass and/or cardiac arrest and/or general anesthesia.
Another object of the present invention is to provide a method and apparatus for the repair of the mitral valve that facilitates the use of smaller incisions.
Another object of the present invention is to provide a method and apparatus to effect a change in the geometry of the annulus of the mitral valve that increases mitral leaflet coaptation and reduces mitral valve regurgitation.
Another object of the present invention is to provide a method and apparatus to effect a change in the geometry of the left atrium that increases mitral leaflet coaptation and reduces mitral regurgitation.
Another object of the present invention is to provide an apparatus that is anchored partially or wholly outside the coronary sinus such that tension can be created between the proximal and distal anchored points so as to move these two points closer together and thereby effect a favorable change in the geometry of the mitral valve annulus.
Another object of the present invention is to provide an apparatus that is anchored partially or wholly outside the coronary sinus such that tension can be created between the proximal and distal anchored points so as to move these two points closer together and thereby effect a favorable change in left atrial geometry, with minimal, if any, trauma to the blood vessel.
Another object of the present invention is to provide a method and apparatus to alter the geometry of the mitral valve annulus such that (1) the distance between the anterior and posterior mitral leaflets is shortened; and (2) the coronary sinus assumes a more straight course.
Another object of the present invention is to provide a method and apparatus to alter left atrial geometry such that (1) the distance between the anterior and posterior mitral leaflets is shortened;
and (2) the coronary sinus assumes a more straight course.
Another object of the present invention is to provide a method and apparatus for altering the geometry of the mitral valve annulus in an adjustable and/or reversible fashion such that the effect on mitral valve function can be adjusted so as to achieve the best possible result.
Another object of the present invention is to provide a method and apparatus for altering left atrial geometry in an adjustable and/or reversible fashion such that the effect on mitral valve function can be adjusted so as to achieve the best possible result.
Another object of the present invention is to provide an apparatus that is anchored partially or wholly outside the coronary sinus such that a greater geometric change in the left atrium can be created (that in turn increases mitral leaflet coaptation and reduces mitral regurgitation) when compared to anchoring only within the coronary sinus.
These and other objects are addressed by the present invention, which is made possible by the discovery that the mitral annulus may be remodeled without the plication of conventional, open-surgery annuloplasty.
The present invention comprises a method and apparatus for increasing mitral leaflet coaptation without direct surgical exposure of the mitral valve via the left atrium. More particularly, the present invention comprises a method and apparatus for effecting a geometric, conformational or dimensional alteration in the annulus of the mitral valve by manipulating cardiac structures external to the left atrium and, in so doing, improving mitral valve function.
In a preferred embodiment, the present invention utilizes access obtained in part via the coronary sinus. The coronary sinus is the largest vein of the heart. During a large portion of its course in the atrioventricular groove, the coronary sinus lies directly beneath the endocardium of the left atrium and adjacent to the posterior annulus of the mitral valve.
An apparatus appropriately placed into the coronary sinus will be in direct apposition to the left atrium and the posterior annulus of the mitral valve.
Manipulation of such apparatus may be used to effect a geometric change in the left atrium, and hence the annulus of the mitral valve, in order to increase mitral leaflet coaptation. Preferably, the apparatus is adjustable so that its effect may be varied, at the time of the initial procedure or at a later date, so as to achieve the best possible result.
In one preferred form of the invention, the apparatus comprises a distal anchor, a proximal anchor and a flexible filament extending therebetween. By setting the distal anchor distally, near the end of'the coronary sinus, and setting the proximal anchor proximally, near the mouth of the coronary sinus, and thereafter adjustably cinching the filament between the two anchors, the geometry of the coronary sinus, and hence the geometry of the left atrium and the mitral valve, may be adjusted so as to improve mitral leaflet coaptation. The effects of this left atrial conformational change include (1) decreasing the distance between the anterior and posterior leaflets of the mitral valve; (2) straightening the posterior mitral valve annulus; and (3) decreasing the distance between the fibrous trigones of the heart by altering the shape of the mitral valve annulus.
Access to perform this procedure may be obtained either percutaneously via any vessel in the body or via a chamber of the heart, such as the right atrium. The latter approach may involve a chest wall incision or a thoracoscopic approach. Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, or real-time magnetic resonance imaging. It is anticipated that assessment of the efficacy of the procedure will be obtained with echocardiography, although other imaging modalities may also be suitable.
An apparatus appropriately placed into the coronary sinus will be in direct apposition to the left atrium and the posterior annulus of the mitral valve.
Manipulation of such apparatus may be used to effect a geometric change in the left atrium, and hence the annulus of the mitral valve, in order to increase mitral leaflet coaptation. Preferably, the apparatus is adjustable so that its effect may be varied, at the time of the initial procedure or at a later date, so as to achieve the best possible result.
In one preferred form of the invention, the apparatus comprises a distal anchor, a proximal anchor and a flexible filament extending therebetween. By setting the distal anchor distally, near the end of'the coronary sinus, and setting the proximal anchor proximally, near the mouth of the coronary sinus, and thereafter adjustably cinching the filament between the two anchors, the geometry of the coronary sinus, and hence the geometry of the left atrium and the mitral valve, may be adjusted so as to improve mitral leaflet coaptation. The effects of this left atrial conformational change include (1) decreasing the distance between the anterior and posterior leaflets of the mitral valve; (2) straightening the posterior mitral valve annulus; and (3) decreasing the distance between the fibrous trigones of the heart by altering the shape of the mitral valve annulus.
Access to perform this procedure may be obtained either percutaneously via any vessel in the body or via a chamber of the heart, such as the right atrium. The latter approach may involve a chest wall incision or a thoracoscopic approach. Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, or real-time magnetic resonance imaging. It is anticipated that assessment of the efficacy of the procedure will be obtained with echocardiography, although other imaging modalities may also be suitable.
Brief Description Of The Drawings The above and other objects and features of the present invention will be more fully disclosed or rendered obvious by the following detailed description of the preferred embodiments of the invention, which is to be considered together with the accompanying drawings wherein like numbers refer to like parts and further wherein:
Fig. 1 is a schematic view of portions of the human vascular system;
Fig. 2 is a schematic view of portions of the human heart;
Fig. 3 is a schematic view showing one embodiment of apparatus formed in accordance with the present invention;
Figs. 4-10 are a series of views illustrating use of the system of Fig. 3 to reduce mitral regurgitation;
Fig. 11 is a schematic view showing another embodiment of apparatus formed in accordance with the present invention; and Fig. 12 is a schematic view showing still another embodiment of apparatus formed in accordance with the present invention.
Detailed Description Of The Preferred Embodiments The coronary sinus is the largest vein in the human heart. During a large portion of its course in the atrioventricular groove, the coronary sinus typically extends adjacent to the left atrium of the heart for a distance of approximately 5 to 10 centimeters. Significantly, for a portion of its length, e.g., typically approximately 7-9 cm, the coronary sinus extends substantially adjacent to the posterior perimeter of the mitral annulus. The present invention takes advantage of this fact. More particularly, by deploying an appropriate apparatus in the coronary sinus, adjacent to the posterior leaflet of the mitral valve, pressure may be brought to bear on the posterior annulus of the mitral valve, whereby to move the posterior annulus anteriorly so as to improve leaflet coaptation and, as a result, reduce mitral regurgitation. In this respect it should be appreciated that the posterior annulus may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e.g., where a leaflet may be tethered due to left ventricular distortion). Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms "improved leaflet coaptation" and/or "increased leaflet coaptation" and the like.
In one preferred embodiment of the invention, access to the coronary sinus is gained percutaneously, e.g., the apparatus is introduced into the patient's vascular system via the jugular vein or via the left subclavian vein, passed down the superior vena cava, passed through the right atrium and then passed into the coronary sinus, where it is deployed.
Alternatively, the apparatus may be introduced into the coronary sinus through a small incision in the heart, or through some other incision into the patient's vascular system.
tJnce deployed, the apparatus may be left in position permanently (e.g., in the case of patients suffering from mitral regurgitation associated with heart failure) or the elongated body may be left in position only temporarily (e.g., in the case of patients suffering from mitral regurgitation associated with acute myocardial infarction).
Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, real-time magnetic resonance imaging, etc. The efficacy of the procedure may be determined through echocardiography, although other imaging modalities may also be suitable.
Looking now at Figs. 1 and 2, there are shown aspects of the cardiovascular system 3 of a patient.
More particularly, cardiovascular system 3 generally comprises the heart 6, the superior vena cava 9, the right subclavian vein 12, the left subclavian vein 15, the jugular vein 18, and the inferior vena cava 21.
Superior vena cava 9 and inferior vena cava 21 communicate with the heart's right atrium 24. The coronary ostium 27 leads to coronary sinus 30. At the far end 31 (Fig. 2) of coronary sinus 30, the vascular structure turns into the vertically-descending anterior interventricular vein ("AIV") 32 (Fig. 1). For purposes of the present invention, it can generally be convenient to consider the term "coronary sinus" to mean the vascular structure extending between coronary ostium 27 and AIV 32.
As seen in Fig. 2, between coronary ostium 27 and AIV 32, coronary sinus 30 generally extends substantially adjacent to the posterior perimeter of the annulus 33 of the mitral valve 36. Mitral valve 36 comprises a posterior leaflet 39 and an anterior leaflet 42. In the case of a regurgitant mitral valve, posterior leaflet 39 and anterior leaflet 42 will generally fail to properly coapt at systole, thereby leaving an intervening gap 45 which will permit regurgitation.
Looking next at Fig. 3, there is shown a system 100 which comprises one preferred embodiment of the present invention. More particularly, system 100 generally comprises a guidewire 103, a cinching device 106 and a delivery cannula 109.
Guidewire 103 comprises a flexible body 112 having a distal end 115 and a proximal end 118. The distal end 115 of guidewire 103 preferably includes a sharp tip 121 for allowing the distal end of guidewire 106 to penetrate tissue.
Fig. 1 is a schematic view of portions of the human vascular system;
Fig. 2 is a schematic view of portions of the human heart;
Fig. 3 is a schematic view showing one embodiment of apparatus formed in accordance with the present invention;
Figs. 4-10 are a series of views illustrating use of the system of Fig. 3 to reduce mitral regurgitation;
Fig. 11 is a schematic view showing another embodiment of apparatus formed in accordance with the present invention; and Fig. 12 is a schematic view showing still another embodiment of apparatus formed in accordance with the present invention.
Detailed Description Of The Preferred Embodiments The coronary sinus is the largest vein in the human heart. During a large portion of its course in the atrioventricular groove, the coronary sinus typically extends adjacent to the left atrium of the heart for a distance of approximately 5 to 10 centimeters. Significantly, for a portion of its length, e.g., typically approximately 7-9 cm, the coronary sinus extends substantially adjacent to the posterior perimeter of the mitral annulus. The present invention takes advantage of this fact. More particularly, by deploying an appropriate apparatus in the coronary sinus, adjacent to the posterior leaflet of the mitral valve, pressure may be brought to bear on the posterior annulus of the mitral valve, whereby to move the posterior annulus anteriorly so as to improve leaflet coaptation and, as a result, reduce mitral regurgitation. In this respect it should be appreciated that the posterior annulus may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e.g., where a leaflet may be tethered due to left ventricular distortion). Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms "improved leaflet coaptation" and/or "increased leaflet coaptation" and the like.
In one preferred embodiment of the invention, access to the coronary sinus is gained percutaneously, e.g., the apparatus is introduced into the patient's vascular system via the jugular vein or via the left subclavian vein, passed down the superior vena cava, passed through the right atrium and then passed into the coronary sinus, where it is deployed.
Alternatively, the apparatus may be introduced into the coronary sinus through a small incision in the heart, or through some other incision into the patient's vascular system.
tJnce deployed, the apparatus may be left in position permanently (e.g., in the case of patients suffering from mitral regurgitation associated with heart failure) or the elongated body may be left in position only temporarily (e.g., in the case of patients suffering from mitral regurgitation associated with acute myocardial infarction).
Visualization of the procedure may be obtained by fluoroscopy, echocardiography, intravascular ultrasound, angioscopy, real-time magnetic resonance imaging, etc. The efficacy of the procedure may be determined through echocardiography, although other imaging modalities may also be suitable.
Looking now at Figs. 1 and 2, there are shown aspects of the cardiovascular system 3 of a patient.
More particularly, cardiovascular system 3 generally comprises the heart 6, the superior vena cava 9, the right subclavian vein 12, the left subclavian vein 15, the jugular vein 18, and the inferior vena cava 21.
Superior vena cava 9 and inferior vena cava 21 communicate with the heart's right atrium 24. The coronary ostium 27 leads to coronary sinus 30. At the far end 31 (Fig. 2) of coronary sinus 30, the vascular structure turns into the vertically-descending anterior interventricular vein ("AIV") 32 (Fig. 1). For purposes of the present invention, it can generally be convenient to consider the term "coronary sinus" to mean the vascular structure extending between coronary ostium 27 and AIV 32.
As seen in Fig. 2, between coronary ostium 27 and AIV 32, coronary sinus 30 generally extends substantially adjacent to the posterior perimeter of the annulus 33 of the mitral valve 36. Mitral valve 36 comprises a posterior leaflet 39 and an anterior leaflet 42. In the case of a regurgitant mitral valve, posterior leaflet 39 and anterior leaflet 42 will generally fail to properly coapt at systole, thereby leaving an intervening gap 45 which will permit regurgitation.
Looking next at Fig. 3, there is shown a system 100 which comprises one preferred embodiment of the present invention. More particularly, system 100 generally comprises a guidewire 103, a cinching device 106 and a delivery cannula 109.
Guidewire 103 comprises a flexible body 112 having a distal end 115 and a proximal end 118. The distal end 115 of guidewire 103 preferably includes a sharp tip 121 for allowing the distal end of guidewire 106 to penetrate tissue.
Cinching device 106 comprises a flexible body or filament 124 having a distal end 127 and a proximal end 130. In the case where central lumen 136 extends from distal end 127 to proximal end 130, central lumen 136 would preferably collapse on itself when guidewire 103 is removed or a portion of guidewire 103 would remain within central lumen 136 to prevent blood from the right atrium from bleeding into the pericardial space 51. See Fig. 4. A distal anchor 139 is disposed at the distal end 127 of flexible body 124 and is preferably constructed from or covered with a material which promotes blood clotting to seal the hole created by the tip of guidewire 106 and distal end 127 of flexible body 124. A proximal anchor 142 is disposed at the proximal end 130 of flexible body 124. Proximal anchor 142 preferably comprises a plurality of radial projections 145 formed on flexible body 124 and a head 146 having a central opening 147 therein. Head 146 is intended to "ratchet" over radial projections 145 so as to be adjustable along flexible body 124. More particularly, by ratcheting head 146 distally or proximally along radial projections 145, the length of filament extending between distal anchor 139 and proximal anchor 142 may be shortened or lengthened as desired. Head 146 also includes one or more holes H
for permitting blood to flow past head 146 when the cinching device is deployed in the body.
Delivery catheter 109 comprises a flexible body 148 having a distal end 151 and a proximal end 154. A
central lumen 157 extends down the length of flexible body 148.
System 100 may be used as follows to reduce mitral regurgitation.
First, using devices and method currently well known to interventional cardiologists any commercially available delivery catheter is passed down the jugular vein 18 (or the left subclavian vein 15) of a patient, down superior vena cava 9, through right atrium 24 of the heart, and then into coronary sinus 30. When the tip of the commercially available delivery catheter is located at or near the entrance of the AIV, guidewire 103 is passed down the center of catheter 109. It will be appreciated that as the commercially available delivery catheter and flexible guidewire 103 are passed down coronary sinus 30, the catheter and guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the catheter and guidewire. Then the guidewire's sharp tip 121 is pushed through the end wall 31 of the coronary sinus, across the intervening tissue 48 and into pericardial space 51 and the commercially available delivery catheter is removed leaving the flexible guidewire 103 in place. See Fig. 4.
Next, cinching device 106 and delivery catheter 109 are passed down over the guidewire 103 until the distal end of the delivery.catheter is positioned in coronary sinus 30. See Fig. 5. More particularly, cinching device 106, with its distal anchor 139 and head 146 of proximal anchor 142 in folded back positions, is loaded into the interior lumen 157 of delivery catheter 109, and then the assembly is fit over guidewire 103, with guidewire 103 being received in central lumen 136 of cinching device 106. Cinching device 106 and delivery catheter 109 are passed down guidewire 103, together, in this position. Again, it will be appreciated that as the cinching device 106 and flexible delivery catheter 109 pass down the coronary sinus, the cinching device and delivery catheter will tend to assume the natural curved shape of the coronary sinus, due to the flexible natures of the cinching device and the delivery catheter.
Then, with the distal end 151 of delivery catheter 109 positioned at the far end 31 of the coronary sinus, the distal end of cinching device 106 is advanced forward, through intervening tissue 48, until it enters pericardial space 51. See Fig. 6. At this point the distal anchor 139 of cinching device 106 deploys. See Fig. 7.
Next, delivery catheter 109 is withdrawn proximally until it's distal end is disposed proximally of the cinching device's proximal anchor 142, whereupon head 146 of the proximal anchor 142 will unfold. See Fig. 8.
Next, the cinching device's head 146 is advanced distally, over ratcheting projections 145, until head 146 engages the coronary ostium 27. Then the proximal end of flexible body 124 is withdrawn proximally, causing the distance between distal anchor 139 and proximal anchor 142 to be reduced, whereby to cause at least a portion of coronary sinus 30 to assume a more straight configuration adjacent to the posterior annulus of mitral valve 36. See Fig. 9. This action causes the posterior annulus of mitral valve 36 to be forced anteriorly, whereby the mitral valve's posterior leaflet 39 will also move anteriorly so as to improve mitral valve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. In this respect it should be appreciated that the posterior annulus may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e.g., where a,leaflet may be tethered due to left ventricular distortion).
Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms "improved leaflet coaptation" and/or "increased leaflet coaptation" and the like. Using standard visualization means (e.g. echocardiography or fluoroscopy), the degree of cinching is adjusted (i.e., either tighter or looser) so as to reduce (or completely eliminate) regurgitation in mitral valve 36.
It should be appreciated that when the cinching device's head 146 is in engagement with coronary ostium 27, blood will be free to flow into the coronary ostium due to the presence of holes H in head 146.
for permitting blood to flow past head 146 when the cinching device is deployed in the body.
Delivery catheter 109 comprises a flexible body 148 having a distal end 151 and a proximal end 154. A
central lumen 157 extends down the length of flexible body 148.
System 100 may be used as follows to reduce mitral regurgitation.
First, using devices and method currently well known to interventional cardiologists any commercially available delivery catheter is passed down the jugular vein 18 (or the left subclavian vein 15) of a patient, down superior vena cava 9, through right atrium 24 of the heart, and then into coronary sinus 30. When the tip of the commercially available delivery catheter is located at or near the entrance of the AIV, guidewire 103 is passed down the center of catheter 109. It will be appreciated that as the commercially available delivery catheter and flexible guidewire 103 are passed down coronary sinus 30, the catheter and guidewire will tend to assume the natural curved shape of the coronary sinus, due to the flexible nature of the catheter and guidewire. Then the guidewire's sharp tip 121 is pushed through the end wall 31 of the coronary sinus, across the intervening tissue 48 and into pericardial space 51 and the commercially available delivery catheter is removed leaving the flexible guidewire 103 in place. See Fig. 4.
Next, cinching device 106 and delivery catheter 109 are passed down over the guidewire 103 until the distal end of the delivery.catheter is positioned in coronary sinus 30. See Fig. 5. More particularly, cinching device 106, with its distal anchor 139 and head 146 of proximal anchor 142 in folded back positions, is loaded into the interior lumen 157 of delivery catheter 109, and then the assembly is fit over guidewire 103, with guidewire 103 being received in central lumen 136 of cinching device 106. Cinching device 106 and delivery catheter 109 are passed down guidewire 103, together, in this position. Again, it will be appreciated that as the cinching device 106 and flexible delivery catheter 109 pass down the coronary sinus, the cinching device and delivery catheter will tend to assume the natural curved shape of the coronary sinus, due to the flexible natures of the cinching device and the delivery catheter.
Then, with the distal end 151 of delivery catheter 109 positioned at the far end 31 of the coronary sinus, the distal end of cinching device 106 is advanced forward, through intervening tissue 48, until it enters pericardial space 51. See Fig. 6. At this point the distal anchor 139 of cinching device 106 deploys. See Fig. 7.
Next, delivery catheter 109 is withdrawn proximally until it's distal end is disposed proximally of the cinching device's proximal anchor 142, whereupon head 146 of the proximal anchor 142 will unfold. See Fig. 8.
Next, the cinching device's head 146 is advanced distally, over ratcheting projections 145, until head 146 engages the coronary ostium 27. Then the proximal end of flexible body 124 is withdrawn proximally, causing the distance between distal anchor 139 and proximal anchor 142 to be reduced, whereby to cause at least a portion of coronary sinus 30 to assume a more straight configuration adjacent to the posterior annulus of mitral valve 36. See Fig. 9. This action causes the posterior annulus of mitral valve 36 to be forced anteriorly, whereby the mitral valve's posterior leaflet 39 will also move anteriorly so as to improve mitral valve leaflet coaptation and thereby reduce (or completely eliminate) mitral valve regurgitation. In this respect it should be appreciated that the posterior annulus may be shifted anteriorly so as to achieve, or to attempt to achieve to the extent anatomically possible, leaflet-to-leaflet engagement or leaflet-to-annulus engagement (e.g., where a,leaflet may be tethered due to left ventricular distortion).
Both of these types of engagement, or targeted engagement, are intended to be encompassed by the terms "improved leaflet coaptation" and/or "increased leaflet coaptation" and the like. Using standard visualization means (e.g. echocardiography or fluoroscopy), the degree of cinching is adjusted (i.e., either tighter or looser) so as to reduce (or completely eliminate) regurgitation in mitral valve 36.
It should be appreciated that when the cinching device's head 146 is in engagement with coronary ostium 27, blood will be free to flow into the coronary ostium due to the presence of holes H in head 146.
At this point the cinching device 106 is locked in position.
System 100 is left in this position until it is no longer needed. In some cases this may mean that system 100 is left in position for a period of a few hours, days or weeks; in other cases system 100 may be substantially permanent. If system 100 is to be left in position, the proximal end of flexible body 124 may be cut away and removed. See Fig. 10. This may be done with an instrument advanced down delivery catheter 109. Then delivery catheter 109 is removed from the patient.
Thus it will be seen that with the present invention, cinching device 106 is positioned in the normally curved portion of the coronary sinus adjacent to the mitral valve's posterior leaflet, with its distal anchor 139 located in pericardial space 51 and its proximal anchor 142 located at the coronary ostium 27. By properly cinching the length of filament 124 between these two anchors, cinching device 106 will cause at least a portion of the coronary sinus to assume a more straight configuration adjacent to the posterior leaflet of the mitral valve. This action will in turn drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation. Thus, by inserting the cinching device 106 into the coronary sinus adjacent to the posterior leaflet of the mitral valve and thereafter cinching it down as appropriate, the annulus of the mitral valve is effectively manipulated so that it will assume an increased radius of curvature.
It has also been found that by inserting the cinching device into the coronary sinus adjacent to the posterior leaflet of the mitral valve, the left ventricle may also be remodeled so as to help alleviate congestive heart failure.
In an alternative embodiment of the invention, the delivery catheter 109 is itself guided into coronary sinus 30 without the use of guidewire 103, and the distal end of cinching device 103 is used to open a path through intervening tissue 48 and into pericardial space 51. In this form of the invention, guidewire 103 may be omitted entirely, and the central lumen 136 in cinching device 106 may also be omitted. However, the distal end of cinching device 106 preferably has a trocar device to help open a path through intervening tissue 48. See, for example, Fig. 11, where system 100 is shown comprising cinching device 106 and delivery catheter 109, and further wherein cinching device 106 comprises a distal trocar 160 to open a path through intervening tissue 48 and into pericardial space 51.
And in another alternative embodiment of the invention, the cinching device's distal anchor 139 and/or its proximal anchor 142 may be replaced with an inflatable balloon anchor. In this case delivery catheter 109 may be adapted so that it is itself guided into coronary sinus 30 without the use of guidewire 103, and the central lumen 136 of cinching device 106 may be used as an inflation lumen. See, for example, Fig. 12, where system 100 is shown comprising cinching device 106 and delivery catheter 109, and further wherein cinching device 106 comprises a distal anchor 139 comprising an inflatable balloon and a distal trocar 160 to open a path through intervening tissue 48 and into pericardial space 51. Central lumen 136 allows fluid to be delivered to and removed from the inflatable balloon, whereby to inflate or deflate the balloon on command.
System 100 is left in this position until it is no longer needed. In some cases this may mean that system 100 is left in position for a period of a few hours, days or weeks; in other cases system 100 may be substantially permanent. If system 100 is to be left in position, the proximal end of flexible body 124 may be cut away and removed. See Fig. 10. This may be done with an instrument advanced down delivery catheter 109. Then delivery catheter 109 is removed from the patient.
Thus it will be seen that with the present invention, cinching device 106 is positioned in the normally curved portion of the coronary sinus adjacent to the mitral valve's posterior leaflet, with its distal anchor 139 located in pericardial space 51 and its proximal anchor 142 located at the coronary ostium 27. By properly cinching the length of filament 124 between these two anchors, cinching device 106 will cause at least a portion of the coronary sinus to assume a more straight configuration adjacent to the posterior leaflet of the mitral valve. This action will in turn drive the posterior annulus of the mitral valve anteriorly, so as to improve leaflet coaptation and thereby reduce mitral regurgitation. Thus, by inserting the cinching device 106 into the coronary sinus adjacent to the posterior leaflet of the mitral valve and thereafter cinching it down as appropriate, the annulus of the mitral valve is effectively manipulated so that it will assume an increased radius of curvature.
It has also been found that by inserting the cinching device into the coronary sinus adjacent to the posterior leaflet of the mitral valve, the left ventricle may also be remodeled so as to help alleviate congestive heart failure.
In an alternative embodiment of the invention, the delivery catheter 109 is itself guided into coronary sinus 30 without the use of guidewire 103, and the distal end of cinching device 103 is used to open a path through intervening tissue 48 and into pericardial space 51. In this form of the invention, guidewire 103 may be omitted entirely, and the central lumen 136 in cinching device 106 may also be omitted. However, the distal end of cinching device 106 preferably has a trocar device to help open a path through intervening tissue 48. See, for example, Fig. 11, where system 100 is shown comprising cinching device 106 and delivery catheter 109, and further wherein cinching device 106 comprises a distal trocar 160 to open a path through intervening tissue 48 and into pericardial space 51.
And in another alternative embodiment of the invention, the cinching device's distal anchor 139 and/or its proximal anchor 142 may be replaced with an inflatable balloon anchor. In this case delivery catheter 109 may be adapted so that it is itself guided into coronary sinus 30 without the use of guidewire 103, and the central lumen 136 of cinching device 106 may be used as an inflation lumen. See, for example, Fig. 12, where system 100 is shown comprising cinching device 106 and delivery catheter 109, and further wherein cinching device 106 comprises a distal anchor 139 comprising an inflatable balloon and a distal trocar 160 to open a path through intervening tissue 48 and into pericardial space 51. Central lumen 136 allows fluid to be delivered to and removed from the inflatable balloon, whereby to inflate or deflate the balloon on command.
In the procedures described above, the distal end of cinching device 106 (and, depending on the embodiment, the distal end of guidewire 103) is described as penetrating all the way through the intervening tissue 48 and into pericardial space 51, so that the distal anchor 139 can be set into pericardial space 51 and bear against the exterior of intervening tissue 48. This arrangement is generally preferred, since it allows greater separation between distal anchor 139 and proximal anchor 142, and since it allows a strong anchoring arrangement highly resistant slippage. However, if desired, it is also possible to set distal anchor 139 into the interior of intervening tissue 51.
Similarly, in the procedures described above, the proximal anchor 142 is described as being set against coronary ostium 27. Again, this arrangement is generally preferred since it allows good anchor separation and it allows a strong anchoring arrangement highly resistant to slippage. However, if desired, it is also possible to set proximal anchor 142 at other locations.
Similarly, in the procedures described above, the proximal anchor 142 is described as being set against coronary ostium 27. Again, this arrangement is generally preferred since it allows good anchor separation and it allows a strong anchoring arrangement highly resistant to slippage. However, if desired, it is also possible to set proximal anchor 142 at other locations.
The procedures described above relate to effecting changes in left atrial geometry using access obtained via the coronary sinus or other cardiac vein. Such procedures might also be performed using access obtained via the circumflex coronary artery. In addition, a similar approach could be used to perform procedures on the tricuspid valve.
It will be understood that the particular devices and methods embodying the invention are shown by way of illustration only and not as limitations of the invention. The principles and features of this invention may be employed in various and numerous embodiments without departing from the scope of the invention.
It will be understood that the particular devices and methods embodying the invention are shown by way of illustration only and not as limitations of the invention. The principles and features of this invention may be employed in various and numerous embodiments without departing from the scope of the invention.
Claims (14)
1. Apparatus for reducing mitral regurgitation, said apparatus comprising:
a cinching device comprising a distal anchor, a proximal anchor, and a flexible body extending therebetween, said distal anchor being adapted to be positioned distal to the distal end of the coronary sinus and said proximal anchor being adapted to be positioned at the coronary ostium, with said flexible body extending through the coronary sinus between said distal anchor and said proximal anchor;
a guidewire; and a delivery catheter, wherein:
at least one of said distal anchor and said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of body between said distal anchor and said proximal anchor may be reduced; and when said distal anchor is positioned distal to the distal end of the coronary sinus and said proximal anchor is positioned at the coronary ostium, with said flexible body extending through the coronary sinus between said distal anchor and said proximal anchor, and said body is thereafter cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor, a force may be exerted on the posterior annulus so as to reduce mitral regurgitation.
a cinching device comprising a distal anchor, a proximal anchor, and a flexible body extending therebetween, said distal anchor being adapted to be positioned distal to the distal end of the coronary sinus and said proximal anchor being adapted to be positioned at the coronary ostium, with said flexible body extending through the coronary sinus between said distal anchor and said proximal anchor;
a guidewire; and a delivery catheter, wherein:
at least one of said distal anchor and said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of body between said distal anchor and said proximal anchor may be reduced; and when said distal anchor is positioned distal to the distal end of the coronary sinus and said proximal anchor is positioned at the coronary ostium, with said flexible body extending through the coronary sinus between said distal anchor and said proximal anchor, and said body is thereafter cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor, a force may be exerted on the posterior annulus so as to reduce mitral regurgitation.
2. The apparatus according to claim 1, wherein said cinching device comprises a central lumen for receiving said guidewire therein.
3. The apparatus according to claim 2, wherein said central lumen collapses upon itself to prevent blood leakage from one chamber to another.
4. Use of a cinching device to reduce mitral regurgitation, said cinching device comprising a distal anchor, a proximal anchor, and a flexible body extending therebetween, said distal anchor being adapted to be positioned distal to the distal end of the coronary sinus and said proximal anchor being adapted to be positioned at the coronary ostium, wherein:
at least one of said distal anchor and said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, said flexible body having been extended through the coronary sinus between said distal anchor and said proximal anchor;
said body has been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
at least one of said distal anchor and said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, said flexible body having been extended through the coronary sinus between said distal anchor and said proximal anchor;
said body has been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
5. The use according to claim 4, wherein said distal anchor has been set in the pericardial space adjacent to the distal end of the coronary sinus.
6. The use according to claim 4, wherein said distal anchor has been set in the intervening tissue located between the pericardial space and the distal end of the coronary sinus.
7. The use according to claim 4, wherein said proximal anchor comprises a plurality of radial projections formed on said body and a head having a central opening therein, the size and construction of said radial projections and said opening being coordinated so as to enable a ratcheting action between said body and said head, and wherein cinching of said body has been achieved by having moved said bead relative to said body.
8. The use according to claim 7, wherein said head has a plurality of openings therein for blood to pass therethrough.
9. The use according to claim 4, wherein said cinching device has been carried to the coronary sinus inside a delivery catheter.
10. The use according to claim 4, wherein said cinching device has been carried to the coronary sinus over a guidewire.
11. The use according to claim 4, wherein said distal anchor has been set through the myocardium tissue and into the left ventrical adjacent to the distal end of the coronary sinus.
12. Use of a cinching device to reduce mitral regurgitation, said cinching device comprising a distal anchor, a proximal anchor, and a flexible body extending therebetween, said distal anchor configured for positioning distal to the distal end of the coronary sinus and said proximal anchor configured for positioning at the coronary ostium, wherein:
said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of said flexible body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, said flexible body having been extended through the coronary sinus between said distal anchor and said proximal anchor;
said distal anchor has been set in the pericardial space adjacent to the distal end of the coronary sinus;
said flexible body bas been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of said flexible body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, said flexible body having been extended through the coronary sinus between said distal anchor and said proximal anchor;
said distal anchor has been set in the pericardial space adjacent to the distal end of the coronary sinus;
said flexible body bas been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
13. Use of a cinching device to reduce mitral regurgitation, said cinching device comprising a distal anchor, a proximal anchor, and a flexible body extending therebetween, said distal anchor configured for positioning distal to the distal end of the coronary sinus and said proximal anchor configured for positioning at the coronary ostium, wherein:
said proximal anchor comprises a plurality of radial projections formed on said flexible body and a bead having a central opening therein, the size and construction of said radial projections and said opening being coordinated so as to enable a ratcheting action between said flexible body and said head, said head having a plurality of openings therein for blood to pass therethrough;
said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of said flexible body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, said flexible body having been extended through the coronary sinus between said distal anchor and said proximal anchor;
said flexible body has been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor, said cinching having been achieved by moving said head relative to said flexible body; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
said proximal anchor comprises a plurality of radial projections formed on said flexible body and a bead having a central opening therein, the size and construction of said radial projections and said opening being coordinated so as to enable a ratcheting action between said flexible body and said head, said head having a plurality of openings therein for blood to pass therethrough;
said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of said flexible body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, said flexible body having been extended through the coronary sinus between said distal anchor and said proximal anchor;
said flexible body has been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor, said cinching having been achieved by moving said head relative to said flexible body; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
14. Use of a cinching device to reduce mitral regurgitation, said cinching device comprising a distal anchor, a proximal anchor, and a flexible body extending therebetween, said distal anchor configured for positioning distal to the distal end of the coronary sinus and said proximal anchor configured for positioning at the coronary ostium, wherein:
said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of said flexible body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, with said flexible body extending through the coronary sinus between said distal anchor and said proximal anchor;
said distal anchor has been set through the myocardium tissue and into the left ventricle adjacent to the distal end of the coronary sinus;
said flexible body has been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
said proximal anchor is configured for ratcheting action relative to said flexible body, such that the length of said flexible body between said distal anchor and said proximal anchor may be reduced;
said distal anchor has been positioned distal to the distal end of the coronary sinus and said proximal anchor has been positioned at the coronary ostium, with said flexible body extending through the coronary sinus between said distal anchor and said proximal anchor;
said distal anchor has been set through the myocardium tissue and into the left ventricle adjacent to the distal end of the coronary sinus;
said flexible body has been cinched so as to reduce the length of said flexible body between said distal anchor and said proximal anchor; and a force has been exerted on the posterior annulus so as to reduce mitral regurgitation.
Applications Claiming Priority (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27815301P | 2001-03-23 | 2001-03-23 | |
US60/278,153 | 2001-03-23 | ||
US27997401P | 2001-03-29 | 2001-03-29 | |
US27997301P | 2001-03-29 | 2001-03-29 | |
US60/279,974 | 2001-03-29 | ||
US60/279,973 | 2001-03-29 | ||
US28003801P | 2001-03-30 | 2001-03-30 | |
US60/280,038 | 2001-03-30 | ||
US28382001P | 2001-04-13 | 2001-04-13 | |
US60/283,820 | 2001-04-13 | ||
US31221701P | 2001-08-14 | 2001-08-14 | |
US60/312,217 | 2001-08-14 | ||
US33948101P | 2001-10-26 | 2001-10-26 | |
US60/339,481 | 2001-10-26 | ||
US34842402P | 2002-01-14 | 2002-01-14 | |
US60/348,424 | 2002-01-14 | ||
US10/068,264 | 2002-02-05 | ||
US10/068,264 US6656221B2 (en) | 2001-02-05 | 2002-02-05 | Method and apparatus for improving mitral valve function |
US10/068,700 US6790231B2 (en) | 2001-02-05 | 2002-02-05 | Apparatus and method for reducing mitral regurgitation |
US10/068,700 | 2002-02-05 | ||
US10/090,968 | 2002-03-05 | ||
US10/090,968 US20020183837A1 (en) | 2001-03-05 | 2002-03-05 | Apparatus and method for reducing mitral regurgitation |
PCT/US2002/008805 WO2002076284A2 (en) | 2001-03-23 | 2002-03-22 | Method and apparatus for reducing mitral regurgitation |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2441886A1 CA2441886A1 (en) | 2002-10-03 |
CA2441886C true CA2441886C (en) | 2009-07-21 |
Family
ID=27582570
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002441886A Expired - Fee Related CA2441886C (en) | 2001-03-23 | 2002-03-22 | Method and apparatus for reducing mitral regurgitation |
Country Status (3)
Country | Link |
---|---|
US (2) | US6890353B2 (en) |
CA (1) | CA2441886C (en) |
WO (1) | WO2002076284A2 (en) |
Families Citing this family (240)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7883539B2 (en) | 1997-01-02 | 2011-02-08 | Edwards Lifesciences Llc | Heart wall tension reduction apparatus and method |
US6050936A (en) | 1997-01-02 | 2000-04-18 | Myocor, Inc. | Heart wall tension reduction apparatus |
US6332893B1 (en) | 1997-12-17 | 2001-12-25 | Myocor, Inc. | Valve to myocardium tension members device and method |
US6260552B1 (en) | 1998-07-29 | 2001-07-17 | Myocor, Inc. | Transventricular implant tools and devices |
SE514718C2 (en) * | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US7192442B2 (en) | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6997951B2 (en) * | 1999-06-30 | 2006-02-14 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US7507252B2 (en) * | 2000-01-31 | 2009-03-24 | Edwards Lifesciences Ag | Adjustable transluminal annuloplasty system |
US6402781B1 (en) * | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
US20080091264A1 (en) | 2002-11-26 | 2008-04-17 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US20060106279A1 (en) * | 2004-05-14 | 2006-05-18 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of a bridge implant having an adjustable bridge stop |
US8956407B2 (en) * | 2000-09-20 | 2015-02-17 | Mvrx, Inc. | Methods for reshaping a heart valve annulus using a tensioning implant |
US7691144B2 (en) | 2003-10-01 | 2010-04-06 | Mvrx, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
US8784482B2 (en) * | 2000-09-20 | 2014-07-22 | Mvrx, Inc. | Method of reshaping a heart valve annulus using an intravascular device |
US20090287179A1 (en) | 2003-10-01 | 2009-11-19 | Ample Medical, Inc. | Devices, systems, and methods for reshaping a heart valve annulus, including the use of magnetic tools |
US6723038B1 (en) | 2000-10-06 | 2004-04-20 | Myocor, Inc. | Methods and devices for improving mitral valve function |
US6602286B1 (en) | 2000-10-26 | 2003-08-05 | Ernst Peter Strecker | Implantable valve system |
US6810882B2 (en) * | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
US7186264B2 (en) * | 2001-03-29 | 2007-03-06 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US7037334B1 (en) | 2001-04-24 | 2006-05-02 | Mitralign, Inc. | Method and apparatus for catheter-based annuloplasty using local plications |
US8202315B2 (en) | 2001-04-24 | 2012-06-19 | Mitralign, Inc. | Catheter-based annuloplasty using ventricularly positioned catheter |
US6800090B2 (en) | 2001-05-14 | 2004-10-05 | Cardiac Dimensions, Inc. | Mitral valve therapy device, system and method |
US6676702B2 (en) * | 2001-05-14 | 2004-01-13 | Cardiac Dimensions, Inc. | Mitral valve therapy assembly and method |
US7052487B2 (en) * | 2001-10-26 | 2006-05-30 | Cohn William E | Method and apparatus for reducing mitral regurgitation |
US6949122B2 (en) | 2001-11-01 | 2005-09-27 | Cardiac Dimensions, Inc. | Focused compression mitral valve device and method |
US7635387B2 (en) | 2001-11-01 | 2009-12-22 | Cardiac Dimensions, Inc. | Adjustable height focal tissue deflector |
US6824562B2 (en) | 2002-05-08 | 2004-11-30 | Cardiac Dimensions, Inc. | Body lumen device anchor, device and assembly |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US7179282B2 (en) | 2001-12-05 | 2007-02-20 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US6793673B2 (en) | 2002-12-26 | 2004-09-21 | Cardiac Dimensions, Inc. | System and method to effect mitral valve annulus of a heart |
US6976995B2 (en) | 2002-01-30 | 2005-12-20 | Cardiac Dimensions, Inc. | Fixed length anchor and pull mitral valve device and method |
US6908478B2 (en) | 2001-12-05 | 2005-06-21 | Cardiac Dimensions, Inc. | Anchor and pull mitral valve device and method |
WO2003055417A1 (en) | 2001-12-28 | 2003-07-10 | Edwards Lifesciences Ag | Delayed memory device |
SE524709C2 (en) * | 2002-01-11 | 2004-09-21 | Edwards Lifesciences Ag | Device for delayed reshaping of a heart vessel and a heart valve |
US6764510B2 (en) | 2002-01-09 | 2004-07-20 | Myocor, Inc. | Devices and methods for heart valve treatment |
US6960229B2 (en) | 2002-01-30 | 2005-11-01 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US7004958B2 (en) | 2002-03-06 | 2006-02-28 | Cardiac Dimensions, Inc. | Transvenous staples, assembly and method for mitral valve repair |
US6797001B2 (en) | 2002-03-11 | 2004-09-28 | Cardiac Dimensions, Inc. | Device, assembly and method for mitral valve repair |
US6752828B2 (en) | 2002-04-03 | 2004-06-22 | Scimed Life Systems, Inc. | Artificial valve |
CA2950492C (en) | 2002-05-08 | 2018-12-04 | Cardiac Dimensions Pty. Ltd. | Device and method for modifying the shape of a body organ |
US7087064B1 (en) | 2002-10-15 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Apparatuses and methods for heart valve repair |
EP1555949A4 (en) | 2002-10-21 | 2009-07-01 | Mitralign Inc | Method and apparatus for performing catheter-based annuloplasty using local plications |
US8979923B2 (en) | 2002-10-21 | 2015-03-17 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
AU2003285943B2 (en) | 2002-10-24 | 2008-08-21 | Boston Scientific Limited | Venous valve apparatus and method |
US7481821B2 (en) | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
US7112219B2 (en) | 2002-11-12 | 2006-09-26 | Myocor, Inc. | Devices and methods for heart valve treatment |
US7404824B1 (en) | 2002-11-15 | 2008-07-29 | Advanced Cardiovascular Systems, Inc. | Valve aptation assist device |
US8187324B2 (en) | 2002-11-15 | 2012-05-29 | Advanced Cardiovascular Systems, Inc. | Telescoping apparatus for delivering and adjusting a medical device in a vessel |
US7981152B1 (en) | 2004-12-10 | 2011-07-19 | Advanced Cardiovascular Systems, Inc. | Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites |
US7485143B2 (en) | 2002-11-15 | 2009-02-03 | Abbott Cardiovascular Systems Inc. | Apparatuses and methods for heart valve repair |
US9149602B2 (en) | 2005-04-22 | 2015-10-06 | Advanced Cardiovascular Systems, Inc. | Dual needle delivery system |
US7335213B1 (en) | 2002-11-15 | 2008-02-26 | Abbott Cardiovascular Systems Inc. | Apparatus and methods for heart valve repair |
US7837729B2 (en) | 2002-12-05 | 2010-11-23 | Cardiac Dimensions, Inc. | Percutaneous mitral valve annuloplasty delivery system |
US7316708B2 (en) | 2002-12-05 | 2008-01-08 | Cardiac Dimensions, Inc. | Medical device delivery system |
US6945957B2 (en) | 2002-12-30 | 2005-09-20 | Scimed Life Systems, Inc. | Valve treatment catheter and methods |
US7314485B2 (en) | 2003-02-03 | 2008-01-01 | Cardiac Dimensions, Inc. | Mitral valve device using conditioned shape memory alloy |
US20040260382A1 (en) | 2003-02-12 | 2004-12-23 | Fogarty Thomas J. | Intravascular implants and methods of using the same |
EP1608297A2 (en) * | 2003-03-18 | 2005-12-28 | St. Jude Medical, Inc. | Body tissue remodeling apparatus |
US20040220654A1 (en) | 2003-05-02 | 2004-11-04 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
US20060136053A1 (en) * | 2003-05-27 | 2006-06-22 | Rourke Jonathan M | Method and apparatus for improving mitral valve function |
US7179291B2 (en) * | 2003-05-27 | 2007-02-20 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US7351259B2 (en) | 2003-06-05 | 2008-04-01 | Cardiac Dimensions, Inc. | Device, system and method to affect the mitral valve annulus of a heart |
US7887582B2 (en) | 2003-06-05 | 2011-02-15 | Cardiac Dimensions, Inc. | Device and method for modifying the shape of a body organ |
WO2004112585A2 (en) * | 2003-06-20 | 2004-12-29 | Medtronic Vascular, Inc. | Valve annulus reduction system |
US7316706B2 (en) | 2003-06-20 | 2008-01-08 | Medtronic Vascular, Inc. | Tensioning device, system, and method for treating mitral valve regurgitation |
US8052751B2 (en) * | 2003-07-02 | 2011-11-08 | Flexcor, Inc. | Annuloplasty rings for repairing cardiac valves |
WO2005018507A2 (en) | 2003-07-18 | 2005-03-03 | Ev3 Santa Rosa, Inc. | Remotely activated mitral annuloplasty system and methods |
US20050015110A1 (en) | 2003-07-18 | 2005-01-20 | Fogarty Thomas J. | Embolization device and a method of using the same |
US7998112B2 (en) | 2003-09-30 | 2011-08-16 | Abbott Cardiovascular Systems Inc. | Deflectable catheter assembly and method of making same |
US7004176B2 (en) | 2003-10-17 | 2006-02-28 | Edwards Lifesciences Ag | Heart valve leaflet locator |
US20060184242A1 (en) * | 2003-10-20 | 2006-08-17 | Samuel Lichtenstein | Method and apparatus for percutaneous reduction of anterior-posterior diameter of mitral valve |
US7056286B2 (en) | 2003-11-12 | 2006-06-06 | Adrian Ravenscroft | Medical device anchor and delivery system |
US7955384B2 (en) * | 2003-11-12 | 2011-06-07 | Medtronic Vascular, Inc. | Coronary sinus approach for repair of mitral valve regurgitation |
WO2005046531A2 (en) * | 2003-11-12 | 2005-05-26 | Medtronic Vascular, Inc. | Coronary sinus approach for repair of mitral valve regurgitation |
US20050143811A1 (en) * | 2003-12-02 | 2005-06-30 | Fidel Realyvasquez | Methods and apparatus for mitral valve repair |
US20050177228A1 (en) * | 2003-12-16 | 2005-08-11 | Solem Jan O. | Device for changing the shape of the mitral annulus |
US7794496B2 (en) | 2003-12-19 | 2010-09-14 | Cardiac Dimensions, Inc. | Tissue shaping device with integral connector and crimp |
US7854761B2 (en) | 2003-12-19 | 2010-12-21 | Boston Scientific Scimed, Inc. | Methods for venous valve replacement with a catheter |
US8128681B2 (en) | 2003-12-19 | 2012-03-06 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7837728B2 (en) | 2003-12-19 | 2010-11-23 | Cardiac Dimensions, Inc. | Reduced length tissue shaping device |
US9526616B2 (en) | 2003-12-19 | 2016-12-27 | Cardiac Dimensions Pty. Ltd. | Mitral valve annuloplasty device with twisted anchor |
US7431726B2 (en) | 2003-12-23 | 2008-10-07 | Mitralign, Inc. | Tissue fastening systems and methods utilizing magnetic guidance |
US8864822B2 (en) | 2003-12-23 | 2014-10-21 | Mitralign, Inc. | Devices and methods for introducing elements into tissue |
US7993397B2 (en) | 2004-04-05 | 2011-08-09 | Edwards Lifesciences Ag | Remotely adjustable coronary sinus implant |
US7641686B2 (en) * | 2004-04-23 | 2010-01-05 | Direct Flow Medical, Inc. | Percutaneous heart valve with stentless support |
US7534259B2 (en) | 2004-05-05 | 2009-05-19 | Direct Flow Medical, Inc. | Nonstented heart valves with formed in situ support |
US7566343B2 (en) | 2004-09-02 | 2009-07-28 | Boston Scientific Scimed, Inc. | Cardiac valve, system, and method |
US7738969B2 (en) | 2004-10-15 | 2010-06-15 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US7887538B2 (en) * | 2005-10-15 | 2011-02-15 | Baxano, Inc. | Methods and apparatus for tissue modification |
US9101386B2 (en) | 2004-10-15 | 2015-08-11 | Amendia, Inc. | Devices and methods for treating tissue |
US8613745B2 (en) | 2004-10-15 | 2013-12-24 | Baxano Surgical, Inc. | Methods, systems and devices for carpal tunnel release |
US8221397B2 (en) * | 2004-10-15 | 2012-07-17 | Baxano, Inc. | Devices and methods for tissue modification |
WO2006044727A2 (en) * | 2004-10-15 | 2006-04-27 | Baxano, Inc. | Devices and methods for tissue removal |
US9247952B2 (en) | 2004-10-15 | 2016-02-02 | Amendia, Inc. | Devices and methods for tissue access |
US20110190772A1 (en) | 2004-10-15 | 2011-08-04 | Vahid Saadat | Powered tissue modification devices and methods |
US7555343B2 (en) | 2004-10-15 | 2009-06-30 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US8430881B2 (en) | 2004-10-15 | 2013-04-30 | Baxano, Inc. | Mechanical tissue modification devices and methods |
US7938830B2 (en) | 2004-10-15 | 2011-05-10 | Baxano, Inc. | Powered tissue modification devices and methods |
US7578819B2 (en) | 2005-05-16 | 2009-08-25 | Baxano, Inc. | Spinal access and neural localization |
US8062300B2 (en) | 2006-05-04 | 2011-11-22 | Baxano, Inc. | Tissue removal with at least partially flexible devices |
US20100004654A1 (en) * | 2008-07-01 | 2010-01-07 | Schmitz Gregory P | Access and tissue modification systems and methods |
US20100331883A1 (en) | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
US8257356B2 (en) | 2004-10-15 | 2012-09-04 | Baxano, Inc. | Guidewire exchange systems to treat spinal stenosis |
US8048080B2 (en) | 2004-10-15 | 2011-11-01 | Baxano, Inc. | Flexible tissue rasp |
US7211110B2 (en) | 2004-12-09 | 2007-05-01 | Edwards Lifesciences Corporation | Diagnostic kit to assist with heart valve annulus adjustment |
CA2595580A1 (en) | 2005-01-20 | 2006-07-27 | Cardiac Dimensions, Inc. | Tissue shaping device |
US7226440B2 (en) * | 2005-01-31 | 2007-06-05 | G & L Consulting, Llc | Method and device for accessing a pericardial space |
US7854755B2 (en) | 2005-02-01 | 2010-12-21 | Boston Scientific Scimed, Inc. | Vascular catheter, system, and method |
US20060173490A1 (en) | 2005-02-01 | 2006-08-03 | Boston Scientific Scimed, Inc. | Filter system and method |
US7878966B2 (en) | 2005-02-04 | 2011-02-01 | Boston Scientific Scimed, Inc. | Ventricular assist and support device |
US7780722B2 (en) | 2005-02-07 | 2010-08-24 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7670368B2 (en) | 2005-02-07 | 2010-03-02 | Boston Scientific Scimed, Inc. | Venous valve apparatus, system, and method |
US7867274B2 (en) | 2005-02-23 | 2011-01-11 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US10219902B2 (en) * | 2005-03-25 | 2019-03-05 | Mvrx, Inc. | Devices, systems, and methods for reshaping a heart valve anulus, including the use of a bridge implant having an adjustable bridge stop |
US7722666B2 (en) | 2005-04-15 | 2010-05-25 | Boston Scientific Scimed, Inc. | Valve apparatus, system and method |
US7357815B2 (en) * | 2005-04-21 | 2008-04-15 | Micardia Corporation | Dynamically adjustable implants and methods for reshaping tissue |
US7500989B2 (en) | 2005-06-03 | 2009-03-10 | Edwards Lifesciences Corp. | Devices and methods for percutaneous repair of the mitral valve via the coronary sinus |
WO2006133294A2 (en) | 2005-06-07 | 2006-12-14 | Direct Flow Medical, Inc. | Stentless aortic valve replacement with high radial strength |
US8012198B2 (en) | 2005-06-10 | 2011-09-06 | Boston Scientific Scimed, Inc. | Venous valve, system, and method |
US8951285B2 (en) | 2005-07-05 | 2015-02-10 | Mitralign, Inc. | Tissue anchor, anchoring system and methods of using the same |
US20080221673A1 (en) * | 2005-08-12 | 2008-09-11 | Donald Bobo | Medical implant with reinforcement mechanism |
US20070038297A1 (en) * | 2005-08-12 | 2007-02-15 | Bobo Donald E Jr | Medical implant with reinforcement mechanism |
US9492277B2 (en) | 2005-08-30 | 2016-11-15 | Mayo Foundation For Medical Education And Research | Soft body tissue remodeling methods and apparatus |
US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
US20070073391A1 (en) * | 2005-09-28 | 2007-03-29 | Henry Bourang | System and method for delivering a mitral valve repair device |
US8092456B2 (en) | 2005-10-15 | 2012-01-10 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US20080086034A1 (en) | 2006-08-29 | 2008-04-10 | Baxano, Inc. | Tissue Access Guidewire System and Method |
US8366712B2 (en) | 2005-10-15 | 2013-02-05 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US8062298B2 (en) | 2005-10-15 | 2011-11-22 | Baxano, Inc. | Flexible tissue removal devices and methods |
US20070173926A1 (en) * | 2005-12-09 | 2007-07-26 | Bobo Donald E Jr | Anchoring system for medical implant |
US7799038B2 (en) | 2006-01-20 | 2010-09-21 | Boston Scientific Scimed, Inc. | Translumenal apparatus, system, and method |
US7637946B2 (en) | 2006-02-09 | 2009-12-29 | Edwards Lifesciences Corporation | Coiled implant for mitral valve repair |
US7749249B2 (en) | 2006-02-21 | 2010-07-06 | Kardium Inc. | Method and device for closing holes in tissue |
WO2007136532A2 (en) | 2006-05-03 | 2007-11-29 | St. Jude Medical, Inc. | Soft body tissue remodeling methods and apparatus |
US20070270688A1 (en) | 2006-05-19 | 2007-11-22 | Daniel Gelbart | Automatic atherectomy system |
US10028783B2 (en) | 2006-06-28 | 2018-07-24 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US8920411B2 (en) | 2006-06-28 | 2014-12-30 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US8449605B2 (en) | 2006-06-28 | 2013-05-28 | Kardium Inc. | Method for anchoring a mitral valve |
US9119633B2 (en) | 2006-06-28 | 2015-09-01 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US11389232B2 (en) | 2006-06-28 | 2022-07-19 | Kardium Inc. | Apparatus and method for intra-cardiac mapping and ablation |
US11285005B2 (en) | 2006-07-17 | 2022-03-29 | Cardiac Dimensions Pty. Ltd. | Mitral valve annuloplasty device with twisted anchor |
US7837610B2 (en) | 2006-08-02 | 2010-11-23 | Kardium Inc. | System for improving diastolic dysfunction |
US20080065205A1 (en) * | 2006-09-11 | 2008-03-13 | Duy Nguyen | Retrievable implant and method for treatment of mitral regurgitation |
JP4943796B2 (en) * | 2006-09-29 | 2012-05-30 | テルモ株式会社 | Medical device |
US8133213B2 (en) | 2006-10-19 | 2012-03-13 | Direct Flow Medical, Inc. | Catheter guidance through a calcified aortic valve |
US7935144B2 (en) | 2006-10-19 | 2011-05-03 | Direct Flow Medical, Inc. | Profile reduction of valve implant |
WO2008091493A1 (en) | 2007-01-08 | 2008-07-31 | California Institute Of Technology | In-situ formation of a valve |
JP5313928B2 (en) | 2007-02-05 | 2013-10-09 | ボストン サイエンティフィック リミテッド | Percutaneous valves and systems |
US8911461B2 (en) | 2007-03-13 | 2014-12-16 | Mitralign, Inc. | Suture cutter and method of cutting suture |
US11660190B2 (en) | 2007-03-13 | 2023-05-30 | Edwards Lifesciences Corporation | Tissue anchors, systems and methods, and devices |
US8845723B2 (en) | 2007-03-13 | 2014-09-30 | Mitralign, Inc. | Systems and methods for introducing elements into tissue |
US20080255447A1 (en) * | 2007-04-16 | 2008-10-16 | Henry Bourang | Diagnostic catheter |
US7881810B1 (en) * | 2007-05-24 | 2011-02-01 | Pacesetter, Inc. | Cardiac access methods and apparatus |
US8828079B2 (en) | 2007-07-26 | 2014-09-09 | Boston Scientific Scimed, Inc. | Circulatory valve, system and method |
US8100820B2 (en) * | 2007-08-22 | 2012-01-24 | Edwards Lifesciences Corporation | Implantable device for treatment of ventricular dilation |
CA2978267A1 (en) | 2007-08-23 | 2009-02-23 | Dfm, Llc | Translumenally implantable heart valve with formed in place support |
EP2194861A1 (en) | 2007-09-06 | 2010-06-16 | Baxano, Inc. | Method, system and apparatus for neural localization |
DE102007043830A1 (en) | 2007-09-13 | 2009-04-02 | Lozonschi, Lucian, Madison | Heart valve stent |
US20090076597A1 (en) * | 2007-09-19 | 2009-03-19 | Jonathan Micheal Dahlgren | System for mechanical adjustment of medical implants |
US8500697B2 (en) * | 2007-10-19 | 2013-08-06 | Pressure Products Medical Supplies, Inc. | Transseptal guidewire |
US8906011B2 (en) | 2007-11-16 | 2014-12-09 | Kardium Inc. | Medical device for use in bodily lumens, for example an atrium |
US8192436B2 (en) | 2007-12-07 | 2012-06-05 | Baxano, Inc. | Tissue modification devices |
US7892276B2 (en) | 2007-12-21 | 2011-02-22 | Boston Scientific Scimed, Inc. | Valve with delayed leaflet deployment |
US7963947B2 (en) * | 2008-01-16 | 2011-06-21 | Pressure Products Medical Supplies, Inc. | Apparatus, system, and method of shielding the sharp tip of a transseptal guidewire |
US8489172B2 (en) | 2008-01-25 | 2013-07-16 | Kardium Inc. | Liposuction system |
US20090287304A1 (en) | 2008-05-13 | 2009-11-19 | Kardium Inc. | Medical Device for Constricting Tissue or a Bodily Orifice, for example a mitral valve |
WO2010009093A2 (en) | 2008-07-14 | 2010-01-21 | Baxano, Inc | Tissue modification devices |
US9314253B2 (en) | 2008-07-01 | 2016-04-19 | Amendia, Inc. | Tissue modification devices and methods |
US8409206B2 (en) | 2008-07-01 | 2013-04-02 | Baxano, Inc. | Tissue modification devices and methods |
US8398641B2 (en) | 2008-07-01 | 2013-03-19 | Baxano, Inc. | Tissue modification devices and methods |
US8006594B2 (en) | 2008-08-11 | 2011-08-30 | Cardiac Dimensions, Inc. | Catheter cutting tool |
WO2010093837A2 (en) * | 2009-02-11 | 2010-08-19 | Tendyne Medical, Inc. | Percutaneous mitral annular stitch to decrease mitral regurgitation |
CA2749673A1 (en) | 2009-03-13 | 2010-09-16 | Baxano, Inc. | Flexible neural localization devices and methods |
US8394102B2 (en) | 2009-06-25 | 2013-03-12 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
WO2011041571A2 (en) | 2009-10-01 | 2011-04-07 | Kardium Inc. | Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valve |
EP2496189A4 (en) | 2009-11-04 | 2016-05-11 | Nitinol Devices And Components Inc | Alternating circumferential bridge stent design and methods for use thereof |
JP2013512765A (en) | 2009-12-08 | 2013-04-18 | アヴァロン メディカル リミテッド | Devices and systems for transcatheter mitral valve replacement |
US9107749B2 (en) | 2010-02-03 | 2015-08-18 | Edwards Lifesciences Corporation | Methods for treating a heart |
US9050066B2 (en) | 2010-06-07 | 2015-06-09 | Kardium Inc. | Closing openings in anatomical tissue |
US8940002B2 (en) | 2010-09-30 | 2015-01-27 | Kardium Inc. | Tissue anchor system |
EP2624791B1 (en) | 2010-10-08 | 2017-06-21 | Confluent Medical Technologies, Inc. | Alternating circumferential bridge stent design |
US9198756B2 (en) | 2010-11-18 | 2015-12-01 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
US9289295B2 (en) | 2010-11-18 | 2016-03-22 | Pavilion Medical Innovations, Llc | Tissue restraining devices and methods of use |
CA2764494A1 (en) | 2011-01-21 | 2012-07-21 | Kardium Inc. | Enhanced medical device for use in bodily cavities, for example an atrium |
US9452016B2 (en) | 2011-01-21 | 2016-09-27 | Kardium Inc. | Catheter system |
US9486273B2 (en) | 2011-01-21 | 2016-11-08 | Kardium Inc. | High-density electrode-based medical device system |
US11259867B2 (en) | 2011-01-21 | 2022-03-01 | Kardium Inc. | High-density electrode-based medical device system |
US9072511B2 (en) | 2011-03-25 | 2015-07-07 | Kardium Inc. | Medical kit for constricting tissue or a bodily orifice, for example, a mitral valve |
US9668859B2 (en) | 2011-08-05 | 2017-06-06 | California Institute Of Technology | Percutaneous heart valve delivery systems |
AU2012299311B2 (en) | 2011-08-11 | 2016-03-03 | Tendyne Holdings, Inc. | Improvements for prosthetic valves and related inventions |
US9827092B2 (en) | 2011-12-16 | 2017-11-28 | Tendyne Holdings, Inc. | Tethers for prosthetic mitral valve |
USD777925S1 (en) | 2012-01-20 | 2017-01-31 | Kardium Inc. | Intra-cardiac procedure device |
USD777926S1 (en) | 2012-01-20 | 2017-01-31 | Kardium Inc. | Intra-cardiac procedure device |
US10827977B2 (en) | 2012-05-21 | 2020-11-10 | Kardium Inc. | Systems and methods for activating transducers |
US9198592B2 (en) | 2012-05-21 | 2015-12-01 | Kardium Inc. | Systems and methods for activating transducers |
US9693832B2 (en) | 2012-05-21 | 2017-07-04 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
WO2014022124A1 (en) | 2012-07-28 | 2014-02-06 | Tendyne Holdings, Inc. | Improved multi-component designs for heart valve retrieval device, sealing structures and stent assembly |
US9675454B2 (en) | 2012-07-30 | 2017-06-13 | Tendyne Holdings, Inc. | Delivery systems and methods for transcatheter prosthetic valves |
US9744037B2 (en) | 2013-03-15 | 2017-08-29 | California Institute Of Technology | Handle mechanism and functionality for repositioning and retrieval of transcatheter heart valves |
US10463489B2 (en) | 2013-04-02 | 2019-11-05 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US9486306B2 (en) | 2013-04-02 | 2016-11-08 | Tendyne Holdings, Inc. | Inflatable annular sealing device for prosthetic mitral valve |
US11224510B2 (en) | 2013-04-02 | 2022-01-18 | Tendyne Holdings, Inc. | Prosthetic heart valve and systems and methods for delivering the same |
US10478293B2 (en) | 2013-04-04 | 2019-11-19 | Tendyne Holdings, Inc. | Retrieval and repositioning system for prosthetic heart valve |
US9610159B2 (en) | 2013-05-30 | 2017-04-04 | Tendyne Holdings, Inc. | Structural members for prosthetic mitral valves |
JP6461122B2 (en) | 2013-06-25 | 2019-01-30 | テンダイン ホールディングス,インコーポレイテッド | Thrombus management and structural compliance features of prosthetic heart valves |
CA2919379C (en) | 2013-08-01 | 2021-03-30 | Tendyne Holdings, Inc. | Epicardial anchor devices and methods |
US10070857B2 (en) | 2013-08-31 | 2018-09-11 | Mitralign, Inc. | Devices and methods for locating and implanting tissue anchors at mitral valve commissure |
WO2015058039A1 (en) | 2013-10-17 | 2015-04-23 | Robert Vidlund | Apparatus and methods for alignment and deployment of intracardiac devices |
CN108403261B (en) | 2013-10-28 | 2021-02-12 | 坦迪尼控股股份有限公司 | Prosthetic heart valves and systems and methods for delivering prosthetic heart valves |
US9526611B2 (en) | 2013-10-29 | 2016-12-27 | Tendyne Holdings, Inc. | Apparatus and methods for delivery of transcatheter prosthetic valves |
WO2016126942A2 (en) | 2015-02-05 | 2016-08-11 | Vidlund Robert M | Expandable epicardial pads and devices and methods for delivery of same |
WO2015120122A2 (en) | 2014-02-05 | 2015-08-13 | Robert Vidlund | Apparatus and methods for transfemoral delivery of prosthetic mitral valve |
US9986993B2 (en) | 2014-02-11 | 2018-06-05 | Tendyne Holdings, Inc. | Adjustable tether and epicardial pad system for prosthetic heart valve |
EP2907479A1 (en) * | 2014-02-18 | 2015-08-19 | Medtentia International Ltd Oy | A system and a method for delivery of an annuloplasty implant |
EP3116409B1 (en) | 2014-03-10 | 2023-07-26 | Tendyne Holdings, Inc. | Devices for positioning and monitoring tether load for prosthetic mitral valve |
US10368936B2 (en) | 2014-11-17 | 2019-08-06 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
US10722184B2 (en) | 2014-11-17 | 2020-07-28 | Kardium Inc. | Systems and methods for selecting, activating, or selecting and activating transducers |
EP3242630A2 (en) | 2015-01-07 | 2017-11-15 | Tendyne Holdings, Inc. | Prosthetic mitral valves and apparatus and methods for delivery of same |
WO2016144391A1 (en) | 2015-03-11 | 2016-09-15 | Mvrx, Inc. | Devices, systems, and methods for reshaping a heart valve annulus |
CA2983002C (en) | 2015-04-16 | 2023-07-04 | Tendyne Holdings, Inc. | Apparatus and methods for delivery, repositioning, and retrieval of transcatheter prosthetic valves |
US10327894B2 (en) | 2015-09-18 | 2019-06-25 | Tendyne Holdings, Inc. | Methods for delivery of prosthetic mitral valves |
ES2777609T3 (en) | 2015-12-03 | 2020-08-05 | Tendyne Holdings Inc | Framework Features for Prosthetic Mitral Valves |
CN113143539A (en) | 2015-12-10 | 2021-07-23 | 姆维亚克斯股份有限公司 | System for reshaping a heart valve annulus |
WO2017117109A1 (en) | 2015-12-28 | 2017-07-06 | Tendyne Holdings, Inc. | Atrial pocket closures for prosthetic heart valves |
US10470877B2 (en) | 2016-05-03 | 2019-11-12 | Tendyne Holdings, Inc. | Apparatus and methods for anterior valve leaflet management |
US11039921B2 (en) | 2016-06-13 | 2021-06-22 | Tendyne Holdings, Inc. | Sequential delivery of two-part prosthetic mitral valve |
CN109640887B (en) | 2016-06-30 | 2021-03-16 | 坦迪尼控股股份有限公司 | Prosthetic heart valve and apparatus and method for delivering same |
WO2018013515A1 (en) | 2016-07-12 | 2018-01-18 | Tendyne Holdings, Inc. | Apparatus and methods for trans-septal retrieval of prosthetic heart valves |
US10390953B2 (en) | 2017-03-08 | 2019-08-27 | Cardiac Dimensions Pty. Ltd. | Methods and devices for reducing paravalvular leakage |
CN111050702B (en) | 2017-07-13 | 2022-07-05 | 坦迪尼控股股份有限公司 | Prosthetic heart valve and apparatus and method for delivering a prosthetic heart valve |
CN111031967B (en) | 2017-08-28 | 2022-08-09 | 坦迪尼控股股份有限公司 | Prosthetic heart valve with tether connection features |
JP7326255B2 (en) * | 2017-09-22 | 2023-08-15 | エイチブイアール カーディオ オーイー | Medical system for annuloplasty |
US11026791B2 (en) | 2018-03-20 | 2021-06-08 | Medtronic Vascular, Inc. | Flexible canopy valve repair systems and methods of use |
US11285003B2 (en) | 2018-03-20 | 2022-03-29 | Medtronic Vascular, Inc. | Prolapse prevention device and methods of use thereof |
US11793641B2 (en) | 2019-03-28 | 2023-10-24 | Hvr Cardio Oy | Medical system for annuloplasty |
EP3831343B1 (en) | 2019-12-05 | 2024-01-31 | Tendyne Holdings, Inc. | Braided anchor for mitral valve |
US11648114B2 (en) | 2019-12-20 | 2023-05-16 | Tendyne Holdings, Inc. | Distally loaded sheath and loading funnel |
US11951002B2 (en) | 2020-03-30 | 2024-04-09 | Tendyne Holdings, Inc. | Apparatus and methods for valve and tether fixation |
EP4199860A1 (en) | 2020-08-19 | 2023-06-28 | Tendyne Holdings, Inc. | Fully-transseptal apical pad with pulley for tensioning |
JP2023554000A (en) | 2020-12-14 | 2023-12-26 | カーディアック・ディメンションズ・プロプライエタリー・リミテッド | Modular preloaded medical implants and delivery systems |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8398782A (en) * | 1982-03-12 | 1983-10-24 | Webster, Wilton W. Jr. | Autoinflatable catheter |
US4669473A (en) * | 1985-09-06 | 1987-06-02 | Acufex Microsurgical, Inc. | Surgical fastener |
CA1303298C (en) * | 1986-08-06 | 1992-06-16 | Alain Carpentier | Flexible cardiac valvular support prosthesis |
US4944745A (en) * | 1988-02-29 | 1990-07-31 | Scimed Life Systems, Inc. | Perfusion balloon catheter |
US4917698A (en) * | 1988-12-22 | 1990-04-17 | Baxter International Inc. | Multi-segmented annuloplasty ring prosthesis |
US5032113A (en) * | 1989-04-13 | 1991-07-16 | Scimed Life Systems, Inc. | Innerless catheter |
US5092889A (en) * | 1989-04-14 | 1992-03-03 | Campbell Robert M Jr | Expandable vertical prosthetic rib |
US5269809A (en) * | 1990-07-02 | 1993-12-14 | American Cyanamid Company | Locking mechanism for use with a slotted suture anchor |
CA2062000A1 (en) * | 1991-03-07 | 1992-09-08 | H. Robert Moorehead | Site-selective reinforced catheter and methods of manufacturing and using the reinforced catheter |
US6821287B1 (en) * | 1991-05-24 | 2004-11-23 | Advanced Cardiovascular Systems, Inc. | Multi-mode vascular catheter system |
FR2683449A1 (en) | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
US5509900A (en) * | 1992-03-02 | 1996-04-23 | Kirkman; Thomas R. | Apparatus and method for retaining a catheter in a blood vessel in a fixed position |
US5263932A (en) * | 1992-04-09 | 1993-11-23 | Jang G David | Bailout catheter for fixed wire angioplasty |
US5332402A (en) * | 1992-05-12 | 1994-07-26 | Teitelbaum George P | Percutaneously-inserted cardiac valve |
US5443481A (en) * | 1992-07-27 | 1995-08-22 | Lee; Benjamin I. | Methods and device for percutaneous sealing of arterial puncture sites |
US5487730A (en) * | 1992-12-30 | 1996-01-30 | Medtronic, Inc. | Balloon catheter with balloon surface retention means |
US6277107B1 (en) * | 1993-08-13 | 2001-08-21 | Daig Corporation | Guiding introducer for introducing medical devices into the coronary sinus and process for using same |
US5545209A (en) * | 1993-09-30 | 1996-08-13 | Texas Petrodet, Inc. | Controlled deployment of a medical device |
US5476506A (en) * | 1994-02-08 | 1995-12-19 | Ethicon, Inc. | Bi-directional crimped graft |
US6051020A (en) * | 1994-02-09 | 2000-04-18 | Boston Scientific Technology, Inc. | Bifurcated endoluminal prosthesis |
US6332896B1 (en) * | 1994-07-14 | 2001-12-25 | Ortho Development Corporation | Orthopaedic implant with proximal collar |
US5569198A (en) * | 1995-01-23 | 1996-10-29 | Cortrak Medical Inc. | Microporous catheter |
US5681345A (en) * | 1995-03-01 | 1997-10-28 | Scimed Life Systems, Inc. | Sleeve carrying stent |
CA2171896C (en) * | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5575799A (en) * | 1995-03-30 | 1996-11-19 | United States Surgical Corporation | Articulating surgical apparatus |
AU6260896A (en) * | 1995-06-06 | 1996-12-24 | Board Of Regents, The University Of Texas System | Electrode system in iontophoretic treatment devices |
US6132438A (en) * | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
CA2179083A1 (en) | 1995-08-01 | 1997-02-02 | Michael S. Williams | Composite metal and polymer locking stents for drug delivery |
US5797951A (en) * | 1995-08-09 | 1998-08-25 | Mueller; Edward Gene | Expandable support member |
JPH09322936A (en) | 1996-06-06 | 1997-12-16 | A S A Sangyo Kk | Catheter for peritoneal dialysis and dialytic liquid container |
US6090136A (en) * | 1996-07-29 | 2000-07-18 | Radiance Medical Systems, Inc. | Self expandable tubular support |
US5755781A (en) * | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US5755778A (en) | 1996-10-16 | 1998-05-26 | Nitinol Medical Technologies, Inc. | Anastomosis device |
US5855565A (en) * | 1997-02-21 | 1999-01-05 | Bar-Cohen; Yaniv | Cardiovascular mechanically expanding catheter |
US5911732A (en) * | 1997-03-10 | 1999-06-15 | Johnson & Johnson Interventional Systems, Co. | Articulated expandable intraluminal stent |
US5800495A (en) * | 1997-03-27 | 1998-09-01 | Sulzer Intermedics Inc. | Endocardial lead assembly |
US5957949A (en) * | 1997-05-01 | 1999-09-28 | World Medical Manufacturing Corp. | Percutaneous placement valve stent |
US6162245A (en) * | 1997-05-07 | 2000-12-19 | Iowa-India Investments Company Limited | Stent valve and stent graft |
US6033436A (en) * | 1998-02-17 | 2000-03-07 | Md3, Inc. | Expandable stent |
US5980570A (en) * | 1998-03-27 | 1999-11-09 | Sulzer Carbomedics Inc. | System and method for implanting an expandable medical device into a body |
US6241746B1 (en) * | 1998-06-29 | 2001-06-05 | Cordis Corporation | Vascular filter convertible to a stent and method |
US6165194A (en) * | 1998-07-24 | 2000-12-26 | Micrus Corporation | Intravascular flow modifier and reinforcement device |
US6328765B1 (en) * | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
US6086599A (en) * | 1999-02-08 | 2000-07-11 | The Regents Of The University Of California | Micro devices using shape memory polymer patches for mated connections |
US6258117B1 (en) * | 1999-04-15 | 2001-07-10 | Mayo Foundation For Medical Education And Research | Multi-section stent |
US6187040B1 (en) * | 1999-05-03 | 2001-02-13 | John T. M. Wright | Mitral and tricuspid annuloplasty rings |
SE514718C2 (en) | 1999-06-29 | 2001-04-09 | Jan Otto Solem | Apparatus for treating defective closure of the mitral valve apparatus |
US7192442B2 (en) | 1999-06-30 | 2007-03-20 | Edwards Lifesciences Ag | Method and device for treatment of mitral insufficiency |
US6402781B1 (en) | 2000-01-31 | 2002-06-11 | Mitralife | Percutaneous mitral annuloplasty and cardiac reinforcement |
US6989028B2 (en) | 2000-01-31 | 2006-01-24 | Edwards Lifesciences Ag | Medical system and method for remodeling an extravascular tissue structure |
US6648874B2 (en) * | 2000-02-28 | 2003-11-18 | Scimed Life Systems, Inc. | Guide catheter with lubricious inner liner |
US6585716B2 (en) * | 2000-04-05 | 2003-07-01 | Biocardia, Inc. | Method of treating the heart |
US6638268B2 (en) | 2000-04-07 | 2003-10-28 | Imran K. Niazi | Catheter to cannulate the coronary sinus |
US6419696B1 (en) * | 2000-07-06 | 2002-07-16 | Paul A. Spence | Annuloplasty devices and related heart valve repair methods |
US6602288B1 (en) * | 2000-10-05 | 2003-08-05 | Edwards Lifesciences Corporation | Minimally-invasive annuloplasty repair segment delivery template, system and method of use |
US7591826B2 (en) | 2000-12-28 | 2009-09-22 | Cardiac Dimensions, Inc. | Device implantable in the coronary sinus to provide mitral valve therapy |
US6810882B2 (en) | 2001-01-30 | 2004-11-02 | Ev3 Santa Rosa, Inc. | Transluminal mitral annuloplasty |
WO2002060352A1 (en) | 2001-01-30 | 2002-08-08 | Ev3 Santa Rosa, Inc. | Medical system and method for remodeling an extravascular tissue structure |
WO2002062408A2 (en) * | 2001-02-05 | 2002-08-15 | Viacor, Inc. | Method and apparatus for improving mitral valve function |
US6676702B2 (en) | 2001-05-14 | 2004-01-13 | Cardiac Dimensions, Inc. | Mitral valve therapy assembly and method |
US6800090B2 (en) | 2001-05-14 | 2004-10-05 | Cardiac Dimensions, Inc. | Mitral valve therapy device, system and method |
US6949122B2 (en) | 2001-11-01 | 2005-09-27 | Cardiac Dimensions, Inc. | Focused compression mitral valve device and method |
US6805710B2 (en) | 2001-11-13 | 2004-10-19 | Edwards Lifesciences Corporation | Mitral valve annuloplasty ring for molding left ventricle geometry |
US6908478B2 (en) | 2001-12-05 | 2005-06-21 | Cardiac Dimensions, Inc. | Anchor and pull mitral valve device and method |
-
2002
- 2002-03-22 WO PCT/US2002/008805 patent/WO2002076284A2/en not_active Application Discontinuation
- 2002-03-22 US US10/104,720 patent/US6890353B2/en not_active Expired - Lifetime
- 2002-03-22 CA CA002441886A patent/CA2441886C/en not_active Expired - Fee Related
-
2005
- 2005-05-06 US US11/125,415 patent/US20050267574A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2441886A1 (en) | 2002-10-03 |
US20050267574A1 (en) | 2005-12-01 |
WO2002076284A3 (en) | 2003-02-27 |
US6890353B2 (en) | 2005-05-10 |
WO2002076284A2 (en) | 2002-10-03 |
US20020183841A1 (en) | 2002-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2441886C (en) | Method and apparatus for reducing mitral regurgitation | |
US6790231B2 (en) | Apparatus and method for reducing mitral regurgitation | |
US6656221B2 (en) | Method and apparatus for improving mitral valve function | |
US7186264B2 (en) | Method and apparatus for improving mitral valve function | |
US7052487B2 (en) | Method and apparatus for reducing mitral regurgitation | |
US7125420B2 (en) | Method and apparatus for improving mitral valve function | |
EP1383448B1 (en) | Apparatus for improving mitral valve function | |
AU2002240288A1 (en) | Method and apparatus for improving mitral valve function | |
US20020183837A1 (en) | Apparatus and method for reducing mitral regurgitation | |
AU2010200752A1 (en) | Method and apparatus for improving mitral valve function | |
AU2006203499B2 (en) | Method and apparatus for improving mitral valve function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20140324 |
|
MKLA | Lapsed |
Effective date: 20140324 |